Carcinogenesis, Vol. 20, No. 8, 1403-1410,
August 1999
© 1999 Oxford University Press
Commentaries |
How many tumor suppressor genes are involved in human lung carcinogenesis?
Biology Division, National Cancer Center Research Institute, 1-1, Tsukiji 5-chome, Chuo-ku, Tokyo 104-0045, Japan
Abstract
To date, only a limited number of tumor suppressor genes have been identified as being inactivated in lung cancer. The p53 and RB genes are frequently inactivated by genetic alterations such as chromosomal deletions and loss-of-function mutations, while the p16 gene is inactivated not only by genetic alterations but also by transcriptional silencing due to hypermethylation. Recently, it was shown that the FHIT gene encompassing the chromosomal fragile site, FRA3B, is also inactivated in a large proportion of lung cancers. Several lines of evidence indicate the presence of additional tumor suppressor genes involved in lung carcinogenesis. Lung cancer cells often show deletions at multiple chromosomal regions, and deletion mapping studies have defined more than 30 regions dispersed on 21 different chromosome arms as candidate tumor suppressor loci. Several chromosomal regions hypermethylated in lung cancer cells and a number of chromosomal fragile sites have been mapped to the regions deleted in lung cancer. These chromosomal loci can harbor unknown tumor suppressor genes inactivated in lung cancer. Studies on the inherited susceptibility to lung cancer in mice have also indicated the presence of additional tumor suppressor genes for lung cancer. Further analyses of these loci should elucidate how many tumor suppressor genes are involved in human lung carcinogenesis. Molecular and functional analyses of those genes will make it possible to fully understand the molecular mechanism of lung carcinogenesis.
Abbreviations: LOH, loss of heterozygosity; NSCLC, non-small cell lung carcinoma; SCLC, small cell lung carcinoma
Notes
1 To whom correspondence should be addressed Email: jyokota{at}gan2.res.ncc.go.jp
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Mounawar, A. Mukeria, F. Le Calvez, R. J. Hung, H. Renard, A. Cortot, C. Bollart, D. Zaridze, P. Brennan, P. Boffetta, et al. Patterns of EGFR, HER2, TP53, and KRAS Mutations of p14arf Expression in Non-Small Cell Lung Cancers in Relation to Smoking History Cancer Res., June 15, 2007; 67(12): 5667 - 5672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-N. Lee, R.-C. Tseng, H.-S. Hsu, J.-Y. Chen, C. Tzao, W. L. Ho, and Y.-C. Wang Epigenetic Inactivation of the Chromosomal Stability Control Genes BRCA1, BRCA2, and XRCC5 in Non-Small Cell Lung Cancer Clin. Cancer Res., February 1, 2007; 13(3): 832 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kitagawa, K. Inoue, S. Sasaki, Y. Hayashi, Y. Matsuo, M. R. Lieber, H. Mizoguchi, J. Yokota, and T. Kohno Prevalent Involvement of Illegitimate V(D)J Recombination in Chromosome 9p21 Deletions in Lymphoid Leukemia J. Biol. Chem., November 22, 2002; 277(48): 46289 - 46297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tomizawa, T. Kohno, H. Kondo, A. Otsuka, M. Nishioka, T. Niki, T. Yamada, A. Maeshima, K. Yoshimura, R. Saito, et al. Clinicopathological Significance of Epigenetic Inactivation of RASSF1A at 3p21.3 in Stage I Lung Adenocarcinoma Clin. Cancer Res., July 1, 2002; 8(7): 2362 - 2368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. McDoniels-Silvers, C. F. Nimri, G. D. Stoner, R. A. Lubet, and M. You Differential Gene Expression in Human Lung Adenocarcinomas and Squamous Cell Carcinomas Clin. Cancer Res., April 1, 2002; 8(4): 1127 - 1138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Haugen Women who smoke: are women more susceptible to tobacco-induced lung cancer? Carcinogenesis, February 1, 2002; 23(2): 227 - 229. [Full Text] [PDF]
|
|
|
|
|
|
K. H. Vahakangas, W. P. Bennett, K. Castren, J. A. Welsh, M. A. Khan, B. Blomeke, M. C. R. Alavanja, and C. C. Harris p53 and K-ras Mutations in Lung Cancers from Former and Never-Smoking Women Cancer Res., June 1, 2001; 61(11): 4350 - 4356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhang, Z. Fan, Y. Gao, Z. Xiao, C. Li, Q. An, and S. Cheng Detecting Bladder Cancer in the Chinese by Microsatellite Analysis: Ethnic and Etiologic Considerations J Natl Cancer Inst, January 3, 2001; 93(1): 45 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Girard, S. Zöchbauer-Müller, A. K. Virmani, A. F. Gazdar, and J. D. Minna Genome-wide Allelotyping of Lung Cancer Identifies New Regions of Allelic Loss, Differences between Small Cell Lung Cancer and Non-Small Cell Lung Cancer, and Loci Clustering Cancer Res., September 1, 2000; 60(17): 4894 - 4906. [Abstract] [Full Text]
|
|
|
|
|
|
J. Yokota Tumor progression and metastasis Carcinogenesis, March 1, 2000; 21(3): 497 - 503. [Abstract] [Full Text] [PDF]
|
|